Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Tasso and ARUP Laboratories Announce Partnership, Combined Offering for Decentralized Clinical Research Biomarker Testing
Tuesday, February 04, 2025Tasso Inc the leading provider of patientcentric clinical grade blood collection solutions and ARUP Laboratories the largest nonprofit clinical and academic reference laboratory in the United States today announced that they have entered into a partn...
BioNTech Completes Acquisition of Biotheus
Monday, February 03, 2025BioNTech SE announced today the completion of the acquisition of Biotheus Biotheus a clinicalstage biotechnology company dedicated to the discovery and development of novel antibodies to address unmet medical needs of patients with oncological or inf...
GV Research Platform and BeCytes Partner to Enhance Access to Certified Hepatocytes & Biological Samples, Advancing Biopharma Research in India
Monday, February 03, 2025GV Research Platform GVRP a leading provider of preclinical research solutions has announced a strategic partnership with BeCytes Biotechnologies to expand access to highquality human and animalderived biological materials for drug discovery and toxi...
RYSTIGGO[®]▼(rozanolixizumab), for generalized myasthenia gravis (gMG), receives EU approval for two new administration methods
Saturday, February 01, 2025UCB a global biopharmaceutical company today announced the CHMP Committee for Medicinal Products for Human Use has issued a positive opinion for the selfadministration of RYSTIGGO rozanolixizumab via an infusion syringe pump or a new manual push syri...
Meiji Seika Pharma Receives Approval for Adding Domestic Manufacturing Sites in Japan for KOSTAIVE®, a Self-amplifying mRNA Vaccine Against COVID-19
Saturday, February 01, 2025Meiji Seika Pharma Co Ltd announced today that it has received approval for a partial amendment to the manufacturing and marketing approval of KOSTAIVE for Intramuscular Injection a selfamplifying mRNA vaccine for protection against COVID to include...
Datopotamab Deruxtecan Recommended for Approval in the EU by CHMP for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
Saturday, February 01, 2025Datopotamab deruxtecan DatoDXd has been recommended for approval in the European Union EU for the treatment of adult patients with unresectable or metastatic hormone receptor HR positive HER negative IHC IHC or IHC ISH breast cancer
